CardiacSense

Backed by a strong IP portfolio that includes developments in optics, mechanics, and signal processing, CardiacSense has developed a unique, state-of-the-art watch for long-term, continuous monitoring of heart arrhythmias (such as atrial fibrillation or cardiac arrest) and blood pressure. The highly accurate CardiacSense watch is currently in the advanced stages of FDA and CE certification. The CardiacSense watch is an enabler of big data analysis and AI backed healthcare since it provides 24/7/365 monitoring of vital signs. CardiacSense CEO Eldad Shemesh, a 20-year veteran of the Israeli Air Force, founded the company in 2012. The expert multidisciplinary team at CardiacSense combines years of clinical, technical, and business experience. Cardiac Sense is backed mostly by private investors and Angel investors. The company is located in Caesarea, Israel.